Tag Archives: act

Actavis Q1 Beats Estimates, Includes Allergan In 2015 Guidance

Specialty-drug giant and IBD 50 stock Actavis (ACT) beat Wall Street’s Q1 estimates Monday and for the first time offered 2015 guidance, including the newly acquired Allergan, which was in line with expectations. Actavis stock was up 3% in early trading Monday and moved above its 10-week moving average. The company said earnings in the quarter rose 23% over the year-earlier quarter to $4.30 a share, 37 cents above analysts’ consensus, according to

Actavis Earnings On Tap After 3 Other IBD 50 Stocks

Earnings season is winding down, but there are still top stocks due to report, including drug giant Actavis (ACT), one of several drug stocks reporting earnings that day, including Intrexon (XON), Impax Laboratories (IPXL) and Juno Therapeutics (JUNO). Actavis is on the IBD 50 list of the very best stocks. Three other IBD 50 stocks — Regeneron Pharmaceuticals (REGN), Monster Beverage (MNST) and Autohome (ATHM) dished out results in the latest

Sucampo Stock Spikes On Bullish Initiation Report

Hot biotech Sucampo Pharmaceuticals (SCMP) rose more than 10% in early trading Monday after Guggenheim launched coverage with a buy rating, seeing multiple growth drivers ahead. Analyst Louise Chen wrote that Sucampo’s constipation drug Amitiza still has growth potential, despite growing competition from Actavis’ (ACT) and Ironwood ‘s (IRWD) Linzess. She added that further indications and formulations of Amitiza that are in development, along with